source
- Moderna pauses norovirus vaccine trial after missing interim analysisModerna announced it will not enroll a new cohort in the phase 3 trial of its mRNA-1403 norovirus vaccine. The decision follows a July interim analysis that showed the vaccine missed its predefine…
- Merck ends Sutro partnership on IL-2 agonist MK-1484 amid routine pipeline prioritizationMerck announced it is discontinuing development of MK-1484, an interleukin-2 agonist created in partnership with Sutro Biopharma. The drug entered clinical testing in 2022 as a monotherapy and in…